RU2106348C1 - [(3,4-дифторфенокси)метил]-оксиран, его рацемическая смесь или энантиомерно чистая (s)-форма и способ его получения - Google Patents

[(3,4-дифторфенокси)метил]-оксиран, его рацемическая смесь или энантиомерно чистая (s)-форма и способ его получения Download PDF

Info

Publication number
RU2106348C1
RU2106348C1 RU95112519/04A RU95112519A RU2106348C1 RU 2106348 C1 RU2106348 C1 RU 2106348C1 RU 95112519/04 A RU95112519/04 A RU 95112519/04A RU 95112519 A RU95112519 A RU 95112519A RU 2106348 C1 RU2106348 C1 RU 2106348C1
Authority
RU
Russia
Prior art keywords
compounds
difluorophenoxy
methyl
enantiomerically pure
formula
Prior art date
Application number
RU95112519/04A
Other languages
English (en)
Russian (ru)
Other versions
RU95112519A (ru
Inventor
Антуан Стокброеккс Раймон
Be]
Артюр Жюль Гровел Жильбер
Original Assignee
Жансен Фармасетика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Жансен Фармасетика Н.В. filed Critical Жансен Фармасетика Н.В.
Publication of RU95112519A publication Critical patent/RU95112519A/ru
Application granted granted Critical
Publication of RU2106348C1 publication Critical patent/RU2106348C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Epoxy Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Paper (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
RU95112519/04A 1991-02-25 1992-02-14 [(3,4-дифторфенокси)метил]-оксиран, его рацемическая смесь или энантиомерно чистая (s)-форма и способ его получения RU2106348C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65964591A 1991-02-25 1991-02-25
PCT/EP1992/000356 WO1992014731A1 (en) 1991-02-25 1992-02-14 4-[(2-BENZOTHIAZOLYL)METHYLAMINO]-α-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINEETHANOL
US659645 1996-06-06

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU9293053624A Division RU2094434C1 (ru) 1991-02-25 1992-02-14 4-[(2-бензтиазолил)метиламино]-альфа-[(3,4-дифторфенокси)метил]-1-пиперидинэтанол в виде рацемической смеси или (s)-формы или его фармацевтически приемлемая соль присоединения кислоты, способ его получения, фармацевтическая композиция, проявляющая противоинфарктное действие на мозговую ткань

Publications (2)

Publication Number Publication Date
RU95112519A RU95112519A (ru) 1997-04-20
RU2106348C1 true RU2106348C1 (ru) 1998-03-10

Family

ID=24646210

Family Applications (2)

Application Number Title Priority Date Filing Date
RU95112519/04A RU2106348C1 (ru) 1991-02-25 1992-02-14 [(3,4-дифторфенокси)метил]-оксиран, его рацемическая смесь или энантиомерно чистая (s)-форма и способ его получения
RU9293053624A RU2094434C1 (ru) 1991-02-25 1992-02-14 4-[(2-бензтиазолил)метиламино]-альфа-[(3,4-дифторфенокси)метил]-1-пиперидинэтанол в виде рацемической смеси или (s)-формы или его фармацевтически приемлемая соль присоединения кислоты, способ его получения, фармацевтическая композиция, проявляющая противоинфарктное действие на мозговую ткань

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU9293053624A RU2094434C1 (ru) 1991-02-25 1992-02-14 4-[(2-бензтиазолил)метиламино]-альфа-[(3,4-дифторфенокси)метил]-1-пиперидинэтанол в виде рацемической смеси или (s)-формы или его фармацевтически приемлемая соль присоединения кислоты, способ его получения, фармацевтическая композиция, проявляющая противоинфарктное действие на мозговую ткань

Country Status (36)

Country Link
US (2) US5434168A (enExample)
EP (2) EP0573473B1 (enExample)
JP (1) JP2825652B2 (enExample)
KR (1) KR0165901B1 (enExample)
CN (3) CN1033454C (enExample)
AT (1) ATE131478T1 (enExample)
AU (1) AU649788B2 (enExample)
BG (1) BG62332B1 (enExample)
CA (1) CA2104000A1 (enExample)
CY (1) CY1924A (enExample)
CZ (1) CZ284705B6 (enExample)
DE (1) DE69206787T2 (enExample)
DK (1) DK0573473T3 (enExample)
DZ (1) DZ1560A1 (enExample)
EE (1) EE02983B1 (enExample)
ES (1) ES2083737T3 (enExample)
FI (1) FI933719A7 (enExample)
GR (1) GR3018692T3 (enExample)
HK (1) HK172296A (enExample)
HU (2) HUT67695A (enExample)
IE (1) IE69567B1 (enExample)
IL (3) IL113837A (enExample)
LV (1) LV11689B (enExample)
MA (1) MA22447A1 (enExample)
MX (1) MX9200777A (enExample)
NO (1) NO300591B1 (enExample)
NZ (2) NZ241592A (enExample)
PL (1) PL168791B1 (enExample)
RO (1) RO112959B1 (enExample)
RU (2) RU2106348C1 (enExample)
SK (1) SK278705B6 (enExample)
TN (1) TNSN92017A1 (enExample)
TW (1) TW218016B (enExample)
WO (1) WO1992014731A1 (enExample)
ZA (1) ZA921341B (enExample)
ZW (1) ZW1992A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
TW282469B (enExample) * 1993-06-11 1996-08-01 Janssen Pharmaceutica Nv
FI971534A0 (fi) * 1994-10-14 1997-04-11 Janssen Pharmaceutica Nv Oraalisia sabelutsolisuspensioita
AU693969B2 (en) * 1994-11-24 1998-07-09 Janssen Pharmaceutica N.V. Lubeluzole intravenous solutions
AU693354B2 (en) * 1995-04-10 1998-06-25 Baxter International Inc. The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
CA2228054A1 (en) * 1995-10-25 1997-05-01 Janssen Pharmaceutica N.V. Lubeluzole n-oxide
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
CA2258165C (en) * 1996-06-27 2009-03-03 Marc Gaston Venet N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
BR9814956A (pt) * 1997-11-10 2000-10-03 Bristol Myers Squibb Co Inibidores de benzotiazol da tirosina cinase de proteìna
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
AU4537500A (en) 1999-05-12 2000-12-05 Neurosearch A/S Ion channel modulating agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2250752B1 (enExample) * 1973-11-09 1979-03-16 Ici Ltd

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963732A (en) * 1973-05-30 1976-06-15 Tiberio Bruzzese Process for preparing dihydroxydiphenylmethane derivatives
US4310658A (en) * 1980-06-18 1982-01-12 Allied Corporation Production of polyester thermally stabilized with an oxirane
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4717760A (en) * 1986-07-10 1988-01-05 The Dow Chemical Company Fluorinated tris-epoxides based on triphenyl methane
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2250752B1 (enExample) * 1973-11-09 1979-03-16 Ici Ltd

Also Published As

Publication number Publication date
FI933719A0 (fi) 1993-08-24
IL100952A (en) 1995-12-31
HK172296A (en) 1996-09-20
GR3018692T3 (en) 1996-04-30
DE69206787T2 (de) 1996-06-05
EP0573473A1 (en) 1993-12-15
KR0165901B1 (en) 1999-01-15
IE69567B1 (en) 1996-10-02
ES2083737T3 (es) 1996-04-16
CS51292A3 (en) 1992-09-16
EP0501552A1 (en) 1992-09-02
ZW1992A1 (en) 1993-09-22
RU2094434C1 (ru) 1997-10-27
AU649788B2 (en) 1994-06-02
CN1064865A (zh) 1992-09-30
CN1033454C (zh) 1996-12-04
JP2825652B2 (ja) 1998-11-18
HU211560A9 (en) 1995-12-28
ATE131478T1 (de) 1995-12-15
US5675027A (en) 1997-10-07
MX9200777A (es) 1992-08-01
TNSN92017A1 (fr) 1993-06-08
IL100952A0 (en) 1992-11-15
LV11689B (en) 1997-08-20
AU1208592A (en) 1992-09-15
HUT67695A (en) 1995-04-28
DE69206787D1 (de) 1996-01-25
FI933719L (fi) 1993-08-24
JPH06505012A (ja) 1994-06-09
CN1113437A (zh) 1995-12-20
US5434168A (en) 1995-07-18
SK278705B6 (sk) 1998-01-14
HU9302395D0 (en) 1993-11-29
LV11689A (lv) 1997-02-20
WO1992014731A1 (en) 1992-09-03
IL113837A (en) 1996-05-14
MA22447A1 (fr) 1992-10-01
NZ248437A (en) 1994-07-26
EE02983B1 (et) 1997-04-15
NO300591B1 (no) 1997-06-23
CY1924A (en) 1997-03-07
BG62332B1 (bg) 1999-08-31
DZ1560A1 (fr) 2002-02-17
CA2104000A1 (en) 1992-08-26
RU95112519A (ru) 1997-04-20
FI933719A7 (fi) 1993-08-24
NZ241592A (en) 1994-07-26
CZ284705B6 (cs) 1999-02-17
ZA921341B (en) 1993-08-24
RO112959B1 (ro) 1998-02-27
BG98068A (bg) 1994-06-30
IL113837A0 (en) 1995-08-31
NO933010L (no) 1993-08-24
TW218016B (enExample) 1993-12-21
CN1043609C (zh) 1999-06-16
PL168791B1 (pl) 1996-04-30
EP0573473B1 (en) 1995-12-13
DK0573473T3 (da) 1996-01-29
IE920575A1 (en) 1992-08-26
NO933010D0 (no) 1993-08-24
CN1117048A (zh) 1996-02-21

Similar Documents

Publication Publication Date Title
RU2106348C1 (ru) [(3,4-дифторфенокси)метил]-оксиран, его рацемическая смесь или энантиомерно чистая (s)-форма и способ его получения
ES2208812T3 (es) Derivados de azetidina y de pirrolidina.
IL275584B1 (en) A process for separating a serial mixture of nicotine
KR20020093974A (ko) 아자비시클릭 카르밤산염 및 알파-７ 니코틴작용아세틸콜린 수용체 아고니스트로서의 이의 용도
KR100523184B1 (ko) 아제티딘 및 피롤리딘의 유도체
US5036090A (en) 3-Aryloxazolidinone derivatives, process for their preparation and their use in therapy
CZ323094A3 (en) Branched amino derivatives of thiazole, process of their preparation and pharmaceutical compositions containing thereof
EP0538080A1 (fr) Dérivés de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique
CN1429197A (zh) 3,3－二芳基丙基胺衍生物的简化合成法
US20080015358A1 (en) Fluorination Process of Protected Aminothiazole
TWI491607B (zh) ４，４’-（１-甲基-１，２-乙二基）-雙-（２，６-哌二酮）之新製法
BG62331B1 (bg) Бензопиран и съответстващи му левкотриен в4 антагонисти
WO1995004028A1 (en) Indane and tetrahydronaphthalene derivatives as calcium channel antagonists
EP1675839B1 (en) Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
JP2009510063A (ja) 特定のトリフルオロメチル置換アルコール類の立体選択的合成
US10189776B2 (en) Stereoselective process
CN100451014C (zh) 制备手性1,4-二取代哌嗪的方法
FR2675504A1 (fr) Derives d'aryl-3 oxazolidinone, leur procede de preparation et leur application en therapeutique.
US4767767A (en) 2-pyrrolidinylethyl-2-(7-trifluoromethyl-4-quinolyl-aminobenzoate having analgesic, antipyretic and anti-inflammatory activities
CN101384260A (zh) 哌嗪衍生物
JP2873898B2 (ja) ベンゾ［ｂ］チオフェン−５−イル誘導体もしくはその光学活性体またはそれらの塩並びにそれらの製造法
JP2004508371A (ja) 置換イミダゾピリジン化合物の製造方法
NO132835B (enExample)
KR20120037913A (ko) 티아벤조아줄렌프로피온산 유도체의 제조법
CN1278249A (zh) 用作药物的联苯基衍生物

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20010215